VYOME HOLDINGS, INC. Deferred Income Tax Assets, Net
VYOME HOLDINGS, INC. (HIND) had Deferred Income Tax Assets, Net of $28.00 thousand as of 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredIncomeTaxAssetsNet · last filed 2025-08-14
- 2025-06-30: Deferred Income Tax Assets, Net $28.00K.
- 2025-03-31: Deferred Income Tax Assets, Net $26.00K.
- 2024-12-31: Deferred Income Tax Assets, Net $22.00K.
- 2024-09-30: Deferred Income Tax Assets, Net $28.00K.
| Period end | Deferred Income Tax Assets, Net |
|---|---|
| 2025-06-30 | $28.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $26.00K 10-Q · filed 2025-05-20 |
| 2024-12-31 | $22.00K 10-Q · filed 2025-08-14 |
| 2024-09-30 | $28.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $27.00K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $27.00K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $28.00K 10-K · filed 2025-04-04 |
| 2023-09-30 | $55.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $57.00K 10-Q · filed 2023-08-07 |
| 2023-03-31 | $57.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $56.00K 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |